Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Antiphospholipid syndrome and the pneumologist]

J C Piette1, P Cacoub, M Karmochkine

  • 1Service de Médecine Interne, Groupe Hospitalier Pitié-Salpêtrière, Paris, France.

Revue De Pneumologie Clinique
|January 1, 1994
PubMed
Summary

Antiphospholipid syndrome (APS) involves blood clots and pregnancy complications, often linked to autoimmune conditions. Respiratory issues like pulmonary embolism and hypertension are significant manifestations requiring long-term prevention strategies.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Nasal septal perforation and systemic disease].

La Revue de medecine interne·2002
Same author

[Rupture of ascending aortic aneurysm revealing Takayasu's arteritis].

Archives des maladies du coeur et des vaisseaux·2002
Same author

[Kidney, lupus and pregnancy].

La Revue de medecine interne·2002
Same author

[ANCA associated glomerulonephritis related to benzylthiouracil].

La Revue de medecine interne·2002
Same author

[Neurological manifestations of Behçet's disease].

Revue neurologique·2002
Same author

Plasma exchange and interferon-alpha pharmacokinetics in patients with hepatitis C virus-associated systemic vasculitis.

Nephron·2002

Area of Science:

  • Rheumatology and Immunology
  • Cardiopulmonary Medicine

Context:

  • Antiphospholipid syndrome (APS) is characterized by thrombosis or pregnancy morbidity in the presence of antiphospholipid antibodies.
  • APS can occur secondary to systemic lupus erythematosus or as a primary condition.
  • Diverse and significant respiratory manifestations are associated with APS.

Purpose:

  • To detail the range of respiratory manifestations in Antiphospholipid Syndrome (APS).
  • To highlight the association between APS and various pulmonary complications.
  • To emphasize the importance of secondary prevention in APS management.

Summary:

  • APS commonly presents with venous or arterial thrombosis and/or pregnancy morbidity, linked to antiphospholipid antibodies.
  • Respiratory manifestations include frequent pulmonary embolism, pulmonary hypertension, and potential involvement in adult respiratory distress syndrome.

Related Experiment Videos

  • Cardiac complications such as heart failure and myocardiopathy can also arise from APS.

    • Impact:

    • Understanding these respiratory and cardiac links is crucial for comprehensive APS diagnosis and patient care.
    • Highlights the need for vigilant monitoring and long-term secondary prevention strategies to reduce recurrent thrombosis in APS patients.
    • Contributes to the knowledge base for managing complex autoimmune disorders with multi-systemic implications.